The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...